Robert Schreiber, PhD

Robert Schreiber, PhD

Primary Academic Title

Andrew M. and Jane M. Bursky Distinguished Professor of Immunobiology, Washington University School of Medicine

Research Interest

Biology and signaling of cytokines with special emphasis on IFN-gamma and TNF; role of IFN-gamma in tumor immunity.

Education

  • 1973: PhD, biochemistry and immunology, State University of New York, Buffalo

Training

  • 1973 - : Postdoctoral fellow, medicine and biochemistry, State University of New York, Buffalo
  • 1973 - 1976: Postdoctoral fellow, molecular immunology, Scripps Research Institute, La Jolla, Calif

Selected Research Publications

Cancer Neoantigen Vaccines Emerge Efficacious.
  • Sultan H, Schreiber RD
  • Annu Rev Med 2026
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy.
  • Sultan H, Takeuchi Y, Ward JP, [...] Schreiber RD
  • Nature 2024
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity.
  • Moynihan KD, Kumar MP, Sultan H, [...] Schreiber RD, [...] Djuretic IM
  • Cancer Discov 2024
TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti-PD-1 tumor immunotherapy.
  • Di Luccia B, Molgora M, Khantakova D, [...] Schreiber RD, [...] Colonna M
  • Sci Immunol 2024

View All Publications